Sedative and Hypnotics Flashcards

1
Q

SEDATIVES – reduce ______ and exert a ______ effect

HYPNOTICS - produces ______ and facilitates the onset and maintenance of _________________

A

anxiety; calming

drowsiness ;a state of sleep.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SEDATIVE/HYPNOTICS ANXIOLYTICS

Major therapeutic use is to relief _______(_______) or induce _______(_______)

A

anxiety (anxiolytics)

sleep (hypnotics).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypnotic effects can be achieved with most anxiolytic drugs

T/F

A

T

just by increasing the dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The distinction between a “pathological” and “normal” state of anxiety is easy to draw

T/F

A

F

hard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

anxiolytics are among the most prescribed substances worldwide.

T/F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Manifestations of anxiety:

Verbal complaints. The patient says he/she is __________________

Somatic and autonomic effects: . The patient is _______ and _______, has ______cardia, _____eased sweating, weeping and often gastrointestinal disorders.

Social effects. Interference with _________________ activities.

A

anxious, nervous, edgy.

restless and agitated; tachycardia, incr

Normal productive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathological Anxiety

Generalized anxiety disorder (GAD): People suffering from GAD have general symptoms of ————, autonomic ______, etc. for at least ________

A

motor tension; hyperactivity

one month.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathological Anxiety

Phobic anxiety:
Simple phobias. Agoraphobia, fear of ______, etc. Social phobias.

.

A

animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathological Anxiety

Panic disorders: Characterized by (acute or chronic ?) attacks of ___ as compared to the (acute or chronic?) presentation of GAD.

A

Acute ; fear

Chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathological Anxiety

Obsessive-compulsive behaviors: These patients show _________(obsessions) and ___________ (compulsions).

A

repetitive ideas

behaviors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of Anxiety

______
_____-induced
Drug ______

A

Medical
Drug-induced
Drug withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of Anxiety
1). Medical:
Respiratory Endocrine Cardiovascular Metabolic Neurologic.

T/F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of Anxiety
2). Drug-Induced:

– Stimulants
_____,_______,_______,_______.

– Sympathomimetics
_______,________,______,________.

– Anticholinergics\Antihistaminergics
________,________,__________,_________

– Dopaminergics
________,________,________,__________

Miscellaneous:
• Baclofen, cycloserine, hallucinogens, indomethacin.

A

Amphetamines, cocaine, TCAs, caffeine

Ephedrine, epinephrine, pseudoephedrine phenylpropanolamine

Trihexyphenidyl, benztropine, meperidine diphenhydramine, oxybutinin.

Amantadine, bromocriptine, L-Dopa, carbid/levodopa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of Anxiety

Drug Withdrawal:
•____,________,_________, other ______,______

A

BDZs, narcotics, BARBs

sedatives, alcohol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Strategy for treatment of anxiety

_______ anxiety without causing ________.

A

Reduce

sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anxiolytics

Barbiturates e.g. ________,______,______,_____,_______

Benzodiazepines e.g._______ (Valium), _____ (Versed),_______ (Klonopin) ; ________ (Ormodon), ________ (Rohypnol)

Glutethimide : ____________

A

Methohexitone, Phenobarbital, Pentabarbital, Thiopentone,Thiamylal

Diazepam; Midazolam; Clonazepam

Nitrazepam; Flunitrazepam

Piperidinediones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anxiolytics

Meprobamate : __________ _______

Alcohols : ______,_________,_________

Buspirone : _________

Zolpidem : _____________

Zaleplon : __________

A

Propanediol carbamates

Ethanol, Chloral hydrate, Paraldehyde

Azaspirodecanedione; Imidazopyridine

Pyrazolopyrimidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

BARBITURATES
Derivatives of ___________

–Hypnotic/anxiolytic effect discovered in the early 20th century (Veronal®, 1903)
– Until the 60s, it was the largest group of _________

– (low or high?) risk of dependence ((mild or severe?) withdrawal symptoms)

A

barbituric acid

hypnotics; high ; severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

BARBITURATES

– (mild or Strong?) depressant activity on the CNS => ________

– At higher doses it causes respiratory and cardiovascular ________ => very little use today as _______ (only for _______ and ________)

A

Strong ; anesthesia

hypnotics

epilepsy and anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Structure-Activity Relationship of Barbiturates

The ________ and ______ forms of barbituric acid with the sites of substitution in the hypnotically active barbiturates

A

keto and enol tautomeric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Structure-Activity Relationship of Barbiturates

Substitution at carbon 5 = *_____ activity is introduced

_______ chain >- greater hypnotic activity

______ group (like ________) -> Greater anticonvulsant activity

Presence of ______philic groups decreases lipophilicity so decreases activity

A

Hypnotic; Branched

Phenol; phenobarbital

hydro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benzodiazepines

_____,_______,_______,_____, and _________ properties.

Treatment : _______

At low doses are useful _______ and high doses produce a ________ effect

A

sedative, hypnotic, anti-anxiety, anticonvulsant, and muscle relaxant

anxiety; sedatives; hypnotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benzodiazepines

Absorption and distribution: ___philic, are (slowly or rapidly?) and (completely or incompletely?) absorbed after _____ administration and distribute throughout the body.

Excreted in the urine as ________ or ______ metabolites.

A

lipo; rapidly ; completely

oral

glucuronides; oxidized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Benzodiazepines

Treatment : anxiety

It has (more or less?) side effects, dependence

It is (more or less?) effective

A

Less

More

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What are the different types of benzodiazepines? Several types with differences in potency, speed at which they are metabolized, and "half-life" and therapeutic use. Vary mostly in their ________
duration of action
26
Benzodiazepines A substituent in the position _____, such as a _______, or ________ group, is required for sedative-hypnotic activity
7 halogen or a nitro
27
benzodiazepines List 4
Clonazepam Diazepam Lorazepam Flunitrazepam
28
Anxiolytics _______ (BZDs). ___________ (BARBs). _________ receptor agonists. _____,______, and ______ receptor antagonists. If ANS symptoms are prominent: _______________ antagonists. _________ agonists (clonidine).
Benzodiazepines (BZDs). Barbiturates (BARBs). 5-HT1A receptor agonists. 5-HT2A, 5-HT2C & 5-HT3 receptor antagonists. ß-Adrenoreceptor Alpha2-AR
29
Anxiolytics Other Drugs with anxiolytic activity. –_____(_______). Used for Obsessive compulsive Disorder. –________. Used in panic attacks. – Anti_____ agents. Present in over the counter medications. – Anti________ (Ziprasidone).
TCAs (Fluvoxamine) MAOIs; histaminic psychotics
30
Anxiolytics Other Drugs with anxiolytic activity. Novel drugs. (Most of these are still on clinical trials). -_____ (e.g. CCK4). –______/_______ (e.g. HA966).
CCKB EAA's/NMDA
31
Anxiolytics Other Drugs with anxiolytic activity. – TCAs (Fluvoxamine). Used for ________________ – MAOIs. Used in _______
Obsessive compulsive Disorder. panic attacks.
32
Sedative/Hypnotics A hypnotic should produce, as much as possible, a state of _____ that resembles _______
sleep normal sleep.
33
Sedative/Hypnosis By definition all sedative/hypnotics will induce sleep at _____ doses. Normal sleep consists of distinct stages, based on three physiologic measures: ____________gram, ______gram, ____________gram.
high electroencephalo; electromyo electronystagmo
34
Sedative/Hypnosis Two distinct phases are distinguished which occur cyclically over —— min: 1)___________(NREM). _____% of total sleep. Has _____ stages. Most sleep leads to stage ____. 2)__________ (REM). Recalled _____.
90 Non-rapid eye movement 70-75; 4; 2 Rapid eye movement; dreams
35
Properties of Sedative/Hypnotics in Sleep 1) The _______ of sleep onset is ____eased (time to ______). 2) The duration of stage ___ ——— sleep is increased. 3) The duration of _____ sleep is decreased. 4) The duration of ___-wave sleep is decreased. Tolerance occurs after ______
latency; Decr; fall asleep 2 NREM; REM slow; 1-2 weeks
36
slow-wave sleep , when ____________ and —————- occur
somnambulism and nightmares
37
Other Properties of Sedative/Hypnotics Some sedative/hypnotics will depress the CNS to stage ______ of anesthesia. Due to their (slow or fast?) onset of action and (short or long?) duration, barbiturates such as _______ and ________ are used as _____ in general anesthesia.
III ; fast ; short thiopental and methohexital adjuncts
38
Sedative/Hypnotics All of the anxiolytics/sedative/hypnotics should be used only for __________ ************* All the drugs used alter the normal _____ and should be administered only for _______________, never for _________. ************ USE FOR _______-TERM TREATMENT ONLY!!
symptomatic relief. sleep cycle days or weeks; months SHORT
39
Barbiturates Long acting ___________ Short acting ___________ , ___________ Ultra-short acting ___________ ___________
Phenobarbitone Butobarbitone ,Pentobarbitone Thiopentone Methohexitone
40
Benzodiazepines Hypnotic List 6 Antianxiety List 5 Anticonvulsant List 4
Diazepam Flurazepam Nitrazepam Alprazolam Temazepam Triazolam Diazepam Chlordiazepoxide Oxazepam Lorazepam Alprazolam Diazepam Lorazepam Clonazepam Clobazam
41
Non Benzodiazepine hypnotics List 3 Miscellaneous List 2
ZOLPIDEM ZALEPLON ZOPICLONE (ESZOPICLONE) MELATONIN RAMELTEON
42
GABA-A Receptor Major player in ______ Synapses. It is a ____ Channel. Binding of GABA causes the channel to ____ and ____ to flow ____ the cell with the resultant membrane _____________.
Inhibitory Cl- ; open Cl- ; into hyperpolarization
43
GABA Receptor Increase in Cl− permeability can depolarize the target cell under some conditions of ________________. This in turn potentially can _____________ or to activate _______ via voltage-gated channels and has been proposed as a physiologically relevant event, especially in embryonic neurons.
high intracellular Cl− excite the cell to fire Ca2+ entry
44
GABA Receptor GABAB receptors were identified by their __________ to the GABAA antagonist _______.
insensitivity; bicuculline
45
GABA Receptor The GABA analog (−) ________ was found to be a potent and selective GABA___ agonist.
baclofen B
46
GABA Receptor Baclofen (__________________________________ acid)
β-(4-chloro-phenyl)-γ-aminobutyric
47
GABAB receptors are coupled (directly or indirectly?) to ___ channels. When activated, these receptors can ____ease _____conductance and ____ cAMP production via intracellular mechanisms mediated by G proteins.
Indirectly; K+ decr; Ca2+; inhibit
48
GABAB receptors can mediate ___________________________________ inhibition.
both postsynaptic and presynaptic
49
GabaB Presynaptic inhibition may occur as a result of GABABreceptors on nerve terminals causing a ____ease in the influx of _____, thereby reducing the release of neurotransmitters. it is known that these _________ increase the frequency of channel opening in response to GABA,
decr; Ca2+ benzodiazepines
50
benzodiazepine site is coupled allosterically to the ______ and ______ sites. Benzodiazepine receptors are _______geneous with respect to affinity for certain ligands. A wide variety of nonbenzodiazepines, such as the _____,________, and ______, also bind to the benzodiazepine site.
barbiturate and picrotoxin hetero β- carbolines, cyclopyrrolones and imidazopyridines
51
Barbiturates • enhance the binding of GABA to ______ receptors •Prolonging ________ •Only _____ (not ____ ) subunits are required for barbiturate action •(wide or narrow?) therapeutic index •in _____ doses, barbiturates increase reactions to painful stimuli.
GABAA; duration α and β ; Υ Narrow; small Hence, they cannot be relied on to produce sedation or sleep in the presence of even moderate pain.
52
Barbiturates can be relied on to produce sedation or sleep in the presence of moderate pain. T/F
F they cannot be relied on to produce sedation or sleep in the presence of even moderate pain.
53
Bezodiazepines • enhance the binding of GABA to ______ receptors •Increasing the ________ •Unlike barbiturates, benzodiazepines do ___________
GABAA frequency not activate GABA
54
BARBITURATES or BENZODIAZEPINES Has a Respiratory depression steeper dose-response relationship than BARBITURATES or BENZODIAZEPINES
BARBITURATES BENZODIAZEPINES
55
BARBITURATES ACTIONS 1. Depression of CNS: At _____ doses, the barbiturates produce _____ (——- effect, reducing ______). 2. Respiratory depression: Barbiturates suppress the ______ and _______ response to CO2, and overdosage is followed by ———- and _________ 3. Enzyme induction: Barbiturates (induce or inhibit?) P450 microsomal enzymes in the liver.
low; sedation; calming ;excitement hypoxic and chemoreceptor; respiratory depression and death. induce
56
BARBITURATES ACTIONS 1. Depression of CNS: At low doses, the barbiturates produce sedation (calming effect, reducing excitement). 2. Respiratory depression: Barbiturates suppress the hypoxic and chemoreceptor response to CO2, and overdosage is followed by respiratory depression and death. 3. Enzyme induction: Barbiturates induce P450 microsomal enzymes in the liver.
57
BARBITURATES PHARMACOKINETICS All barbiturates redistribute in the body. Barbiturates are metabolized in the ____, and inactive metabolites are excreted in the ________.
liver urine
58
BARBITURATES PHARMACOKINETICS Toxicity: Extensions of CNS depressant effects dependence liability (> or
>
59
BARBITURATES PHARMACOKINETICS Interactions: Additive CNS depression with ________ and many other drugs (induction or inhibition?) of hepatic drug-metabolizing enzymes.
ethanol induction
60
Barbiturates readily cross the placenta and can depress the fetus. T/F
T
61
THERAPEUTIC USES ANESTHESIA (THIOPENTAL, METHOHEXITAL) Selection of a barbiturate is strongly influenced by the desired _________________________ The ultra______-acting barbiturates, such as thiopental, are used _______________ to induce anesthesia.
duration of action. short; intravenously
62
THERAPEUTIC USES ANESTHESIA (THIOPENTAL, METHOHEXITAL) ANXIETY Barbiturates have been used as (mild or severe ?) sedatives to relieve anxiety, nervous tension, and insomnia. When used as hypnotics, they suppress ________ more than other stages. However, most have been replaced by the _______________.
mild; REM sleep benzodiazepines
63
THERAPEUTIC USES ANTICONVULSANT: (PHENOBARBITAL, MEPHOBARBITAL) Phenobarbital is used in (short or long?) -term management of _______ seizures, status ___________, and eclampsia.
Long tonic-clonic ; epilepticus
64
THERAPEUTIC USES ANTICONVULSANT: (PHENOBARBITAL, MEPHOBARBITAL) However, phenobarbital can depress ____________ in children, and the drug should be used ______.
cognitive performance; cautiously
65
THERAPEUTIC USES ANTICONVULSANT: (PHENOBARBITAL, MEPHOBARBITAL) Phenobarbital has specific _________ activity that is distinguished from the ___________ CNS depression.
anticonvulsant nonspecific
66
___________ has been regarded as the drug of choice for treatment of young children with recurrent febrile seizures.
Phenobarbital
67
Adverse effects of Barbiturates CNS: Barbiturates cause drowsiness, impaired _________ Drug hangover: Hypnotic doses of barbiturates produce a feeling of _________ well after the patient wakes. Barbiturates (induce or inhibit?) the P450 system.
concentration ; tiredness Induce
68
Adverse effects of Barbiturates Drug hangover: By inducing ___________________, barbiturates increase porphyrin synthesis, and are contraindicated in patients with ____________________
aminolevulinic acid (ALA) synthetase acute intermittent porphyria.
69
ADVERSE EFFECTS of Barbiturates Physical dependence: Abrupt withdrawal from barbiturates may cause ______, anxiety, weakness, ________, nausea and vomiting, seizures, delirium, and _____________ Poisoning: Barbiturate poisoning has been a leading cause of death resulting from drug overdoses for many decades. It may be due to ____________
tremors; restlessness; cardiac arrest. automatism
70
Barbiturates: adverse effects Severe depression of _______ is coupled with _______________ depression, and results in a _____-like condition with shallow, infrequent breathing.
respiration central cardiovascular shock
71
THE TREATMENT OF ACUTE BARBITURATE INTOXICATION Treatment includes _______ and ________________________ if the drug has been recently taken.
artificial respiration ; purging the stomach of its contents
72
Mention 2 specific barbiturate antagonist
No specific barbiturate antagonist is available.
73
THE TREATMENT OF ACUTE BARBITURATE INTOXICATION General supportive measures. ___________ or ___________ is necessary only rarely. Use of CNS ______________ is contraindicated because they increase the mortality rate.
Hemodialysis or hemoperfusion stimulants
74
THE TREATMENT OF ACUTE BARBITURATE INTOXICATION If renal and cardiac functions are satisfactory, and the patient is hydrated, __________ and ___________ of the urine will hasten the excretion of phenobarbital. In the event of renal failure - _________ circulatory collapse is a major threat. So __________ must be corrected & blood pressure can be supported with ———. Acute renal failure consequent to ______ and ________ accounts for perhaps one-sixth of the deaths.
forced diuresis and alkalinization hemodialysis; hypovolemia; dopamine shock and hypoxia
75
Effects of benzodiazepine On increasing the dose, sedation progresses to ______ and then to ________. But the drugs do not cause a true general anesthesia because - ________________________ -___________________ to allow surgery cannot be achieved. However at "preanesthetic" doses, there is ________.
hypnosis; stupor awareness usually persists -immobility sufficient amnesia
76
Effects of benzodiazepines on the (EEG) and Sleep Stages _____eased sleep latency _____eased number of awakenings _____eased time spent in stage 0, 1, 3, 4 _____eased time spent in REM sleep (_____eased number of cycles of REM sleep) ____eased total sleep time (largely by increasing the time spent in stage ___)
Decr; Decr Decr; Decr incr; Incr 2
77
Respiration-Hypnotic doses of benzodiazepines are (with or without?) effect on respiration in normal subjects CVS-In preanesthetic doses, all benzodiazepines ____ease blood pressure and ____ease heart rate
without decr incr
78
PHARMACOKINETICS of benzodiazepines A (short or long?) elimination half-life is desirable for hypnotics, although this carries the drawback of increased _____________ and ____________ after drug discontinuation. Most of the BZDs are metabolized in the ____ to produce (active or inactive ?) products (thus long duration of action). After metabolism these are ______ and are excreted via ________.
Short abuse liability and severity of withdrawal liver; active conjugated; kidney
79
ADVERSE EFFECTS of BZDs Light-headedness, Fatigue ____eased reaction time Motor _______ _______,__________ amnesia
Incr; incoordination Confusion, Antero-grade
80
Adverse effect of BZDs ________ appears to be affected less than ___________. All of these effects can greatly impair _______ and other psychomotor skills, especially if combined with ———-.
Cognition motor performance driving; ethanol
81
FLUMAZENIL: A BENZODIAZEPINE RECEPTOR ANTAGONIST competitively antagonism Flumazenil antagonizes both the electrophysiological and behavioral effects of agonist and inverse-agonist ___________ and _________. Flumazenil is available only for ________ administration.
benzodiazepines and β -carbolines intravenous
82
FLUMAZENIL: A BENZODIAZEPINE RECEPTOR ANTAGONIST On intravenous administration, flumazenil is eliminated almost entirely by hepatic metabolism to (active or inactive?) products with a t1/2 of ~________ ; the duration of clinical effects usually is only _________
Inactive 1 hour 30-60 minutes.
83
FLUMAZENIL: A BENZODIAZEPINE RECEPTOR ANTAGONIST PRIMARY INDICATIONS FOR THE USE OF FLUMAZENIL ARE:- Management of suspected ________________ Reversal of _______ effects produced by benzodiazepines administered The administration of _________ injections is preferred to ———— injection.
benzodiazepine overdose. sedative a series of small a single bolus
84
Novel Benzodiazepine Receptor Agonists Z compounds ________,________,_________,____________ structurally (related or unrelated?) to each other and to benzodiazepines
zolpidem , zaleplon , zopiclone and eszopiclone Unrelated
85
Novel Benzodiazepine Receptor Agonists Z compounds therapeutic efficacy as hypnotics is due to agonist effects on the ______ site of the _____ receptor
benzodiazepine; GABAA
86
Novel Benzodiazepine Receptor Agonists Z compounds Compared to benzodiazepines, Z compounds are -(more or less?) effective as anticonvulsants or muscle relaxants -which may be related to their relative selectivity for ______ receptors containing the ____ subunit.
Less GABAA α1
87
The clinical presentation of overdose with Z compounds is similar to that of benzodiazepine overdose and can be treated with the ____________________
benzodiazepine antagonist flumazenil.
88
Zaleplon and zolpidem are effective in relieving sleep-onset ______. Both drugs have been approved by the FDA for use for up to __________ at a time. ________ and _______ have sustained hypnotic efficacy without occurrence of rebound insomnia on abrupt discontinuation.
insomnia 7-10 days Zaleplon and zolpidem
89
RAMELTEON Synthetic tricyclic analog of _________. It was approved for the treatment of _______, specifically ________ difficulties.
MELATONIN; insomnia sleep onset
90
RAMELTEON MECHANISM OF ACTION of melatonin Melatonin levels in the _______ nucleus rise and fall in a circadian fashion concentrations increasing in the _____ as an individual prepares for sleep, and then reaching a ______ and ultimately ____easing as the night progresses.
suprachiastmatic evening; plateau decr
91
MELATONIN CONGENERS Mechanism of Action Two GPCRs for melatonin, MT1 and MT2, are found in the suprachiasmatic nucleus, each playing a different role in sleep. RAMELTEON binds to both MT1 and MT2 receptors with (low or high?) affinity. Binding of Melatonin to MT1 receptors promotes _____________ Binding of Melatonin to MT2 receptors _————- of the circadian system.
High; the onset of sleep. shifts the timing
92
RAMELTEON is efficacious in combating _____________ insomnia
both transient and chronic
93
Management of Patients after Long-Term Treatment with Hypnotic Agents If a benzodiazepine has been used regularly for >2 weeks, it should be ______ rather than ____________. In some patients on hypnotics with a short t1/2, it is easier to switch first to a hypnotic with a ______ and then to _______. The onset of withdrawal symptoms from medications with a long t1/2 may be _____. Consequently, the patient should be warned about the symptoms associated with withdrawal effects.
tapered; discontinued abruptly long t1/2(taper; delayed
94
Atypical Anxiolytics List 3
Buspiron Ipsapirone Gepirone
95
Buspirone relieves ______ without causing marked ______, hypnotic, or euphoric effects. - no _______ or _________ properties. Buspirone does not interact directly with ________ systems.
anxiety; sedative anticonvulsant or muscle relaxant GABAergic
96
Anxiolytic effects of buspirone is by acting as a _________ at brain ________ receptors.
partial agonist 5-HT1A
97
Buspirone the anxiolytic effects of buspirone may take more than ______ unsuitable for management of ______ states ____ rebound anxiety or withdrawal signs on abrupt discontinuance
a week; acute anxiety no
98
Buspirone The drug is effective in blocking the acute withdrawal syndrome resulting from abrupt cessation of use of benzodiazepines or other sedative-hypnotics
F The drug is not effective in blocking the acute withdrawal syndrome resulting from abrupt cessation of use of benzodiazepines or other sedative-hypnotics
99
Buspirone has (minimal or maximal?) abuse liability The drug is used in _______ states but is less effective in _____ disorders
Minimal generalized anxiety panic
100
True statement about zolpidem: A. Relieve sleep onset insomnia B. Cause profound rebound insomnia C. Cause profound REM suppression D. Has strong anticonvulsant effect
A
101
Which is NOT true about Flumazenil? A. Acts on GABAA receptor B. Specific antagonist of benzodiazepine C. Given intravenously D. May be used in barbiturate poisoning
D
102
Administration of barbiturate is contraindicated in: A. Kernicterus B. Anxiety C. Epilepsy D. Acute Intermittant porphyria
D
103
Benzodiazepines act by: A. Activating GABAA receptors directly B. Modulating the effects of GABA on GABAA receptors C. Antagonistic effect on GABAA receptors D. GABA mimetic effect
B
104
Benzodiazepine antagonist is: A. Naloxone B. Zolpidem C. Nalorphine D. Flumazenil
D
105
Beta carboline at benzodiazepine receptor act as: A. Agonist B. Inverse agonist C. Antagonist D. Partial agonist
B
106
True statement about effect of bezodiazepines on sleep is: A. Time spent in stage 2 is decreased B. Time spent in stages 1, 3 and 4 is increased C. Shortening of REM sleep D. Increase sleep latency
C
107
An ideal hypnotic drug should NOT have: A. rapid onset of action B. sustained effect throughout the night C. without any residual effect in the following morning D. increase in sleep latency
D
108
Which one of the following effects is NOT seen with barbiturates? A. Analgesic B. Anticonvulsant C. Induction and maintenance of anaesthesia D. Sedation
A
109
Sleep promoting effect of ramelteon is mediated by receptor: A. GABAA receptor B. Opiate receptors C. GABAB receptor D. Melatonin receptors MT1 and MT2
D